Responses of human basilar and other isolated arteries to novel nitric oxide donors

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 5, 1998, Pages 695-701

  Kimura, Masahide ^a,b   White, Richard P ^a   Wolf, Erich W ^a   Robertson, James T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Basilar arteries; Nitric oxide donors; Vasodilation

Indexed keywords

DIETHYLAMINE NITRIC OXIDE ADDUCT; DIETHYLENETRIAMINE NITRIC OXIDE ADDUCT; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; COMMON CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BASILAR ARTERY; DINOPROST; DOGS; HUMANS; METHYLENE BLUE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROPRUSSIDE; POTASSIUM CHLORIDE; SWINE; VASODILATION;

EID: 0031790553     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199811000-00003     Document Type: Article

References (42)

1. Kontos HA. Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke 1993;24(suppl I):I-155-8.
2. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke 1994;25:692-03.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
4. Drabkin D. Spectrophotometric studies: preparation from washed blood cells: nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 1935;112:51-65.
5. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. New York: Raven Press, 1988:401-14.
6. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971-82.
7. Afshar JKB, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1995;83:118-22.
8. Egeman N, Turker RK, Sanlidilek U, et al. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 1993;15:310-5.
9. Frazee JG, Giannotta SL, Stern WE. Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg 1981;55:865-8.
10. Heros RC, Zervas NT, Lavyne MH. Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol 1976;6:227-9.
11. Kistler JP, Lees RS, Candia G, Zervas NT, Crowell RM, Ojemann RG. Intravenous nitroglycerin in experimental cerebral vasospasm: a preliminary report. Stroke 1979;10:26-9.
12. Thomas JE, Nemirovsky A, Zelman V, Giannotta SL. Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 1997;40: 1245-9.
13. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5.
14. Kowaluk EA, Seth P, Fung HL. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 1992;262:916-22.
15. Morley D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK. Mechanism of vascular relaxation induced by the nitric oxide (NO) nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 1993;21:670-6.
16. Hanson SR, Hutsell TC, Keefer LK, Mooradian DL, Smith DJ, Nitric oxide donors: a continuing opportunity in drug design. Adv Pharmacol 1995;34:383-98.
17. White RP, Shirasawa Y, Robertson JT. Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries. Blood Vessels 1984;21:12-22.
18. White RP, Robertson JT. Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm. Neurosurgery 1987;21:523-31.
19. White RP. Comparison of vasorelaxants in human basilar arteries and umbilical arteries. Eur J Pharmacol 1988;155:109-15.
20. Allen GS, Henderson LM, Chou SN, French LA. Cerebral arterial spasm. Part I: In vitro contractile activity of vasoactive agents on canine basalar and middle cerebral arteries. J Neurosurg 1974;40:433-41.
21. Shirasawa Y, White RP, Robertson JT. Mechanisms of the contractile effect induced by uridine 5-triphosphate in canine cerebral arteries. Stroke 1983;14:347-55.
22. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-16.
23. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993;22(suppl 7):S3-9.
24. Fleming WW, Westfall DF, De LaLande IS, Jellett LB. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 1972;181:339-15.
25. Rapoport RM, Waldman SA, Ginsberg R, Molina CR, Murad F. Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery. J Cardiovasc Pharmacol 1987;10:82-9.
26. Kaufmann MA, Castelli I, Pargger H, Drop LJ. Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharmacol Exp Ther 1995;273:855-62.
27. Stamler JS, Simon DI, Osborne JA, et al. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 1992;89:444-8.
28. Clarke SD, Armstrong MK. Cellular lipid binding proteins: expression, function, and nutritional regulation. FASEB J 1989;3:2480-7.
29. Wolf EW, Banerjee A, Soble-Smith J, White RP, Robertson JT. Reversal of cerebral vasospasm using an intrathecally administered long-acting nitric oxide donor (DETA/NONOate) [Abstract]. J Neurosurg 1997;86:336.
30. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect on NO release rate on vascular smooth muscle proliferation in vivo. J Cardiovasc Pharmacol 1995;25:674-8.
31. Mayberg MR, Okada T, Bark DH. Morphologic changes in cerebral arteries after subarachnoid hemorrhage. Neurosurg Clin North Am 1990;1:401-15.
32. Hatake K, Wakabayashi I, Kakishita E, Hishida S. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke 1992;23:1111-7.
33. Toda N, Okamura T. Role of nitric oxide in neurally induced cerebroarterial relaxation. J Pharmacol Exp Ther 1991;258:1027-32.
34. Onoue H, Kaito N, Tokudome S, et al. Investigation of postmortem functional changes in human cerebral arteries. J Cereb Blood Flow Metab 1993;13:346-9.
35. Bergh CM, Brophy CM, Dansfield DT, Lincoln T, Goldenring JR, Rasmussen H. Impaired cyclic nucleotide-dependent vasorelaxation in human umbilical artery smooth muscle. Am J Physiol 1995;268:H202-12.
36. Molina CR, Andresen JW, Rapoport RM, Waldman S, Murad F. Effect of in vivo nitroglycerin therapy on endothelium-dependent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 1987;10:371-8.
37. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77:842-7.
38. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-carotid papaverine. J Neurosurg 1992;77:848-52.
39. Ohhashi T, Azuma T. Paradoxical relaxation of arterial strips induced by vasoconstriction agents. Blood Vessels 1980;17:16-26.
40. Bevan JA. Sites of transition between functional systemic and cerebral arteries of rabbits occur at embryological junction sites. Science 1979;204:635-7.
41. Chapleau CE, White RP. Effects of prostacyclin on the canine isolated basilar artery. Prostaglandins 1979;17:573-80.
42. Kim P, Schini VB, Sundt TM, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992;70:248-56.